PlainPharmaWatch

CMS Open Payments · Program Year 2024

Louisiana

Louisiana received $33,421,329.94 in pharmaceutical-industry payments to 11,906 physicians and 23 teaching hospitals across 330,247 transactions.

$33.4M
Total payments
$25.3M
To physicians
$3.9M
To teaching hospitals
#28
of 59 states

In CMS Open Payments Program Year 2024, pharmaceutical and medical-device companies reported $33.4M in payments to 11,906 physicians and 23 teaching hospitals in Louisiana. That ranks Louisiana #28 of 59 states and territories (0.2% of the US total), averaging $2.1K per physician. Figures are company-reported under the Physician Payments Sunshine Act; a reported payment is a financial relationship, not evidence of wrongdoing.

The verdict

Louisiana pairs above-median payment volume with a physician-heavy payment mix.

#28
of 59 states
0.2%
of the national total
75.7%
to physicians vs. hospitals
11,906
physicians paid

What the Data Shows for Louisiana

Louisiana's Open Payments file is hospital-weighted: 11.5% of $33.4M went to 23 teaching hospitals ($167.7K each), with 75.7% on 11,906 physicians.

Volume rank is #28 of 59: mid-pack dollars with the mix as the distinctive cut. Average transaction $101.20. Leading nature of payment: "Compensation for Services Other Than Consulting" at $8.3M (24.8% of the state file; top-three natures 65.9%).

Louisiana sits in the 54th percentile (lower-volume tier). Just above: Kansas ($33.6M). Just below: Hawaii ($32.9M). For context: top-ranked California ($342.4M) is 10.2× larger than Louisiana. CMS Sunshine Act framework and methodology.

Physician vs Hospital Payments

How pharmaceutical payments in Louisiana are distributed between physicians and teaching hospitals.

Physician Payments

$25.3M

75.7% of total · 11,906 recipients · $2.1K avg

Teaching Hospital Payments

$3.9M

11.5% of total · 23 hospitals · $167.7K avg

Payment Breakdown by Type

Louisiana has 16 types of pharmaceutical payments. "Compensation for Services Other Than Consulting" accounts for 24.8%.

Nature concentration in Louisiana

Top three Open Payments natures are 65.9% of state dollars; residual is every other reported nature

Compensation for Services Ot…$8.3MFood and Beverage$8.0MConsulting Fee$5.8MAll other natures (13)$11.4M

Payment categories in Louisiana

Top categories by total reported dollar volume

1. Compensation for Services…$8.3M2. Food and Beverage$8.0M3. Consulting Fee$5.8M4. Travel and Lodging$2.8M5. Grant$2.8M6. Royalty or License$1.8M7. Education$956.0K8. Long-Term Medical Supply …$722.0K9. Honoraria$564.0K10. Compensation for Faculty…$563.5K
Payment Type Amount Transactions
Compensation for Services Other Than Consulting $8.3M 3,632
Food and Beverage $8.0M 311,351
Consulting Fee $5.8M 1,981
Travel and Lodging $2.8M 8,849
Grant $2.8M 111
Royalty or License $1.8M 165
Education $956.0K 2,453
Long-Term Medical Supply or Device Loan $722.0K 476
Honoraria $564.0K 229
Compensation for Faculty or Speaker (Medical Education) $563.5K 288
Acquisitions $512.3K 5
Space Rental or Facility Fees $404.3K 140
Debt Forgiveness $126.1K 67
Charitable Contribution $61.3K 11
Gift $52.8K 439
Entertainment $11.3K 50

Data Source: Centers for Medicare & Medicaid Services (CMS) Open Payments, Program Year 2024. Data includes general payments, research payments, and physician ownership/investment interests as required by the Physician Payments Sunshine Act. Total industry payments: $13.9B across 1,925 companies.

Source: CMS Open Payments Database Industry payments to physicians and teaching hospitals · 2024

What Louisiana totals can and cannot tell you

The aggregate payment figure for Louisiana measures reportable industry–physician engagement inside this state's geographic footprint for Program Year 2024, not any one physician's or hospital's relationship with industry. CMS collects the data under the Physician Payments Sunshine Act; manufacturers must report transfers of value above the de minimis threshold. The file does not capture DTC advertising, internal R&D, wholesale drug pricing, or salary support that is not a reportable transfer of value.

Correlations between payment receipt and prescribing appear in peer-reviewed work for specific drugs and specialties, but this page's state total does not establish causation. Open the company and recipient detail pages for category and year-over-year cuts.

View saved (states)
Download Louisiana's data (CSV)
Embed this widget

Copy this snippet to embed a live-linked card on your own site.

Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.